Skip to content

First cancer vaccine approved for use in people – New Scientist

May 6

The latest weapon in the war on cancer is a patient’s own cells. A prostate cancer vaccine that the US Food and Drug Administration rejected in 2007 has now won the regulator’s approval, making it the first cancer vaccine to do so.

Administering Provenge involves harvesting a patient’s immune cells and exposing them to a protein produced by prostate tumours. These “primed” cells are then re-injected into the patient, where they attack tumours.

Though modest, the latest result shows that harnessing the immune system is a viable way to fight cancer. Oncologist Philip Kantoff at the Dana-Farber Cancer Institute in Boston led the trial. He expects similar approaches to other cancers, such as melanoma, kidney cancer and lymphoma, to be approved in five to 10 years and that tweaks to Provenge will see it further extend people’s lives.

Full Article

Advertisements
No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: